BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 4665820)

  • 41. The use of different drugs and combinations in the treatment of Hodgkin's disease.
    Fairley GH
    Ser Haematol; 1973; 6(2):196-201. PubMed ID: 4784374
    [No Abstract]   [Full Text] [Related]  

  • 42. Chemotherapeutic implications of staging in Hodgkin's disease.
    DeVita VT; Carbone PP
    Cancer Res; 1971 Nov; 31(11):1838-44. PubMed ID: 4941352
    [No Abstract]   [Full Text] [Related]  

  • 43. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
    Klein HO
    Hamatol Bluttransfus; 1976; 18():135-45. PubMed ID: 786808
    [No Abstract]   [Full Text] [Related]  

  • 44. [Hodgkin's disease in the practice of general medicine. Problems posed by the diagnosis, surveillance of treatments and social rehabilitation of patients].
    Huart M
    Rev Prat; 1974 Oct; 24(45):3995-8. PubMed ID: 4216953
    [No Abstract]   [Full Text] [Related]  

  • 45. Greater curability in advanced Hodgkin's disease?
    Portlock CS
    Cancer J Sci Am; 1999; 5(5):264-5. PubMed ID: 10526665
    [No Abstract]   [Full Text] [Related]  

  • 46. Prognosis and survival with extranodal Hodgkin's disease.
    McLaren JH; Papac RJ
    J Chronic Dis; 1974 Nov; 27(9-10):447-57. PubMed ID: 4139168
    [No Abstract]   [Full Text] [Related]  

  • 47. Hodgkin's disease of the bone marrow.
    Rosenberg SA
    Cancer Res; 1971 Nov; 31(11):1733-6. PubMed ID: 5121677
    [No Abstract]   [Full Text] [Related]  

  • 48. International Symposium on Hodgkin's Disease. Session 4. Small group workshops. Report on workshop: Chemotherapy.
    Carbone PP
    Natl Cancer Inst Monogr; 1973 May; 36():357-8. PubMed ID: 4126719
    [No Abstract]   [Full Text] [Related]  

  • 49. [Polychemotherapy of Hodgkin's lymphoma. 3. Stage IV].
    Lauria F; Baccarani M; Bagnara GP; Gugliotta L; Ricci P; Santucci MA; Tura S
    Haematologica; 1972; 57(9):536-42. PubMed ID: 4199308
    [No Abstract]   [Full Text] [Related]  

  • 50. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
    Brunner KW; Maurice P; Sonntag RW
    Schweiz Med Wochenschr; 1972 Oct; 102(43):1546-51. PubMed ID: 4647016
    [No Abstract]   [Full Text] [Related]  

  • 51. International Symposium on Hodgkin's Disease. Session 5. Treatment. Current status of clinical trials: Stanford experience, 1962-72.
    Kaplan HS; Rosenberg SA
    Natl Cancer Inst Monogr; 1973 May; 36():363-71. PubMed ID: 4582994
    [No Abstract]   [Full Text] [Related]  

  • 52. [Combination chemotherapy in Hodgkin's disease].
    Andersson T; Landberg T; Möller TR
    Lakartidningen; 1974 May; 71(18):1844-6. PubMed ID: 4597780
    [No Abstract]   [Full Text] [Related]  

  • 53. Updated Hodgkins' disease. C. Advanced disease and special problems. Advances in chemotherapy.
    Frei E; Luce JK
    JAMA; 1973 Jan; 223(2):166-8. PubMed ID: 4739456
    [No Abstract]   [Full Text] [Related]  

  • 54. Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP.
    Bloomfield CD; Weiss RB; Fortuny I; Vosika G; Kennedy BJ
    Cancer; 1976 Jul; 38(1):42-8. PubMed ID: 947533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination chemotherapy in the treatment of advanced Hodgkin's disease.
    Sacks P; Jacobs P; Gale D; Lynch SR; Bothwell TH; Stevens K
    S Afr Med J; 1973 Jun; 47(21):903-7. PubMed ID: 4351107
    [No Abstract]   [Full Text] [Related]  

  • 56. MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.
    Moore MR; Jones SE; Bull JM; William LA; Rosenberg SA
    Cancer; 1973 Jul; 32(1):52-60. PubMed ID: 4716784
    [No Abstract]   [Full Text] [Related]  

  • 57. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
    Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R
    Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination chemotherapy in Hodgkin's disease.
    Nordentoft AM; Jensen KB
    Dan Med Bull; 1973 Mar; 20(2):52-60. PubMed ID: 4688460
    [No Abstract]   [Full Text] [Related]  

  • 59. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
    Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B
    Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination radiotherapy and chemotherapy in the treatment of early Hodgkin's disease.
    Brace K; Serpick AA; Block JB; Wiernik PH
    Oncology; 1973; 27(6):484-92. PubMed ID: 4582588
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.